These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7801146)

  • 21. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection.
    de Silva TI; Cope A; Goepel J; Greig JM
    J Infect; 2007 Apr; 54(4):e207-10. PubMed ID: 17197031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
    Garavelli PL; Berti P
    Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.
    Armitage JO
    Blood; 1998 Dec; 92(12):4491-508. PubMed ID: 9845514
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
    Fisher DC; Peters WP
    Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of cytokines in the treatment of human cancers].
    Marty M; Extra JM; Dieras V
    Pathol Biol (Paris); 1990 Oct; 38(8):783-5. PubMed ID: 1703291
    [No Abstract]   [Full Text] [Related]  

  • 29. Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis: is there a role?
    Trapnell BC
    Am J Respir Crit Care Med; 2002 Jul; 166(2):129-30. PubMed ID: 12119219
    [No Abstract]   [Full Text] [Related]  

  • 30. [Granulocytopoiesis growth factors. II. Clinical applications].
    Skotnicki AB; Dabrowski L
    Przegl Lek; 1990; 47(9):651-8. PubMed ID: 2287753
    [No Abstract]   [Full Text] [Related]  

  • 31. [Advances in new clinical application of recombinant human granulocyte-macrophage colony-stimulating factor].
    Huang HQ; Wang XX
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):429-31. PubMed ID: 22781809
    [No Abstract]   [Full Text] [Related]  

  • 32. Granulocyte-macrophage colony-stimulating factor-related eosinophilia and Loeffler's endocarditis.
    Donhuijsen K; Haedicke C; Hattenberger S; Hauswaldt C; Freund M
    Blood; 1992 May; 79(10):2798. PubMed ID: 1586727
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor.
    Wong L; Taylor CW; Radwanski E; Hersh EM; Salmon SE
    J Immunother Emphasis Tumor Immunol; 1995 Jul; 18(1):57-65. PubMed ID: 8535572
    [No Abstract]   [Full Text] [Related]  

  • 34. Granulocyte-macrophage colony-stimulating factor.
    Betcher DL; Burnham N
    J Pediatr Oncol Nurs; 1991 Jul; 8(3):134-5. PubMed ID: 1930804
    [No Abstract]   [Full Text] [Related]  

  • 35. Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability study.
    Dieterle A; Gratwohl A; Ritz R; Obrecht JP; Obrist R
    Ann Oncol; 1991 Jan; 2(1):69-70. PubMed ID: 2009237
    [No Abstract]   [Full Text] [Related]  

  • 36. Healing of chronic leg ulcers in the hemoglobinopathies with perilesional injections of granulocyte-macrophage colony-stimulating factor.
    Voskaridou E; Kyrtsonis MC; Loutradi-Anagnostou A
    Blood; 1999 May; 93(10):3568-9. PubMed ID: 10366256
    [No Abstract]   [Full Text] [Related]  

  • 37. Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19.
    Mu X; Liu K; Li H; Wang FS; Xu R
    Cell Mol Immunol; 2021 Aug; 18(8):2057-2058. PubMed ID: 34282298
    [No Abstract]   [Full Text] [Related]  

  • 38. The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary.
    Bodey GP
    Eur J Clin Microbiol Infect Dis; 1994 May; 13(5):363-6. PubMed ID: 8070447
    [No Abstract]   [Full Text] [Related]  

  • 39. Radio-immunotherapy: the focused beam expands.
    Frey B; Gaipl US
    Lancet Oncol; 2015 Jul; 16(7):742-3. PubMed ID: 26095779
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiotherapy: abscopal responses: pro-immunogenic effects of radiotherapy.
    Hutchinson L
    Nat Rev Clin Oncol; 2015 Sep; 12(9):504. PubMed ID: 26169925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.